CrkL is required for donor T cell migration to GvHD target organs

The success of cancer therapies based on allogeneic hematopoietic stem cell transplant relies on the ability to separate graft-versus-host disease (GvHD) from graft-versus-tumor (GVT) responses. Controlling donor T cell migration into peripheral tissues is a viable option to limit unwanted tissue da...

Descripción completa

Detalles Bibliográficos
Autores principales: Roy, Nathan H., Mammadli, Mahinbanu, Burkhardt, Janis K., Karimi, Mobin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197453/
https://www.ncbi.nlm.nih.gov/pubmed/32391120
http://dx.doi.org/10.18632/oncotarget.27509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197453/
https://www.ncbi.nlm.nih.gov/pubmed/32391120
http://dx.doi.org/10.18632/oncotarget.27509

Ejemplares similares